Introduction: Malignant skin neoplasms remain a critical issue in the state of Pará, because of its geographical location near the equatorial line, the population is exposed to higher levels of solar radiation thereby increasing the risk of these tumors. Despite public educational campaigns towards more frequent sunscreen use, morbidity and mortality rates are still concerning. Therefore, it’s essential to keep track of reported cases in order to develop strategies for early interventions with the intent of reducing mortality and morbidity rates. Objective: To analyze the epidemiological profile of hospital morbidity and mortality due to malignant skin neoplasms (ICD-10: C44) in Pará from 2020-2025, to inform the development of effective public health strategies. Methods: This is an epidemiological study based in an observational and quantitative structure. The data were obtained through government platform DATASUS, using the Hospital Morbidity System of SUS (SIH/SUS) and the Mortality Information System of SUS (SIM/SUS), all data refer to the state of Pará between the years of 2020-2025. The study analyzed reported cases and deaths that happened in the state of Pará while taking in account their sex, age and race. Results: The data analysis recorded 350 hospitalizations by malignant skin neoplasms during the analyzed period, with 37 deaths and a mortality rate of 10,57%. Among the municipalities, the highest concentration was observed in Belém (154 hospitalizations and 28 deaths, with a mortality rate of 18,18%). Furthermore, the hospitalizations were predominant in males (188 cases and 21 deaths), and in patients with 60-69 years (74 cases and 11 deaths), presenting the highest mortality rate (14,86%). Moreover, a racial analysis comproves that mixed race people (pardo) were the most affected (260 cases and 26 deaths). Conclusion: The data study reveals that between 2020-2025, among the municipalities, the capital Belém held the highest statistics of the hospitalizations and deaths due to malignant skin neoplasms as a result of it acting as the main oncological referral center in the state, contributing to increased hospital lethality. The higher mortality rate in male patients may be attributed to lower adherence to preventive measures and low initiative towards seeking medical assistance, besides among the 60–69 age group, there may be an association with comorbidities, reduced immunity, and greater difficulty in adhering to treatment. Furthermore, it cannot be ruled out that the high hospital morbidity among mixed-race individuals reflects the demographic composition of the state and the socioeconomic factors potentially affecting access to diagnosis and its continuity. In addition, the high hospitality rate in Belém is a major problem to the city’s health system, because the hospitals usually treat most of the oncological cases of the whole state; they are always over-encumbered, diminishing the quality of the healthcare provided to belém’s inhabitants. In conclusion, it is essential to strengthen the oncology care network in the interior regions of the state, reducing the late transfer of severe cases to the capital.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
